Global Comparator Drug Sourcing Market Growth (Status and Outlook) 2023-2029

Global Comparator Drug Sourcing Market Growth (Status and Outlook) 2023-2029

The global Comparator Drug Sourcing market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Comparator Drug Sourcing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Comparator Drug Sourcing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Comparator Drug Sourcing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Comparator Drug Sourcing players cover AmerisourceBergen Corporation, Avantor, Inc., Catalent, Clinical Services International (CSI), Clinigen Clinical Supplies Management, Intertek Group, MCKESSON CORPORATION, Myonex and PHARMA’S ALMANAC, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

Comparator drug sourcing is a sourcing approach whereby the comparator product is accepted within a single country and used in a clinical trial inside the same country. The product evades charges on import and export and regulations, which is considered to speed up the clinical trial supply chain and is cost-effective.

LPI (LP Information)' newest research report, the “Comparator Drug Sourcing Industry Forecast” looks at past sales and reviews total world Comparator Drug Sourcing sales in 2022, providing a comprehensive analysis by region and market sector of projected Comparator Drug Sourcing sales for 2023 through 2029. With Comparator Drug Sourcing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Comparator Drug Sourcing industry.

This Insight Report provides a comprehensive analysis of the global Comparator Drug Sourcing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Comparator Drug Sourcing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Comparator Drug Sourcing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Comparator Drug Sourcing and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Comparator Drug Sourcing.

This report presents a comprehensive overview, market shares, and growth opportunities of Comparator Drug Sourcing market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Local Sourcing
Central Sourcing
Market Sourcing

Segmentation by application
Drug Producers/Manufacturers
CMO
Academic and Research Institute
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
AmerisourceBergen Corporation
Avantor, Inc.
Catalent
Clinical Services International (CSI)
Clinigen Clinical Supplies Management
Intertek Group
MCKESSON CORPORATION
Myonex
PHARMA’S ALMANAC
Sharp Services, LLC
Thermo Fisher Scientific
TransCelerate BioPharma Inc.

Please note: The report will take approximately 2 business days to prepare and deliver.